Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Read More > January 16, 2020
Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity Read More > January 13, 2020
Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients Read More > January 13, 2020
Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT Read More > January 8, 2020
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species Read More > January 7, 2020
Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity. Read More > December 20, 2019
Esketamine is approved in Europe for treating resistant major depressive disorder Read More > December 20, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Read More > December 18, 2019
